logo
  • Home
  • MYO Technology
  • MYO Applications
  • Team
  • News & Events
  • Contact us
  • Home
  • MYO Technology
  • MYO Applications
  • Team
  • News & Events
  • Contact us
https://www.renbio.com/news_and_events/renbio-is-excited-to-provide-an-update-on-our-ultra-long-acting-glp-1-receptor-agonist-program/

BioTech News & Events

RenBio’s COO, Neal Padte, presents on “Antibody Gene Transfer by In Vivo Electroporation” at the “3rd World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies.” 

September 4, 2019

Learn more here:

https://wc2019.electroporation.net/

Related Articles

RenBio is excited to provide an update on our ultra long-acting GLP-1 receptor agonist program.

Read More

RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO TechnologyTM Platform for Antiviral Applications

Read More

ASGCT 27th Annual Meeting in Baltimore

Read More
More News & Events
RenBio Logo
30-02 48th Avenue
Long Island City, NY
© 2025 Renbio
  • Home
  • MYO Technology
  • MYO Applications
  • Team
  • News & Events
  • Contact us
  • FCOI Policy
linkedin logo